Cell Reports
Volume 28, Issue 6, 6 August 2019, Pages 1447-1454.e4
ReportThe GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release
Under a Creative Commons license
open access
Graphical Abstract
Keywords
dapagliflozin
liraglutide
GLP1R
glucagon
insulin
somatostatin
type 2 diabetes
Cited by (0)
- 11
Lead Contact
© 2019 The Author(s).